{Reference Type}: Journal Article
{Title}: Prediction of Long-Term Treatment Outcomes for Diabetic Macular Edema Using a Generative Adversarial Network.
{Author}: Baek J;He Y;Emamverdi M;Mahmoudi A;Nittala MG;Corradetti G;Ip M;Sadda SR;
{Journal}: Transl Vis Sci Technol
{Volume}: 13
{Issue}: 7
{Year}: 2024 Jul 1
{Factor}: 3.048
{DOI}: 10.1167/tvst.13.7.4
{Abstract}: <B>UNASSIGNED: </B>The purpose of this study was to analyze optical coherence tomography (OCT) images of generative adversarial networks (GANs) for the prediction of diabetic macular edema after long-term treatment.<BR><B>UNASSIGNED: </B>Diabetic macular edema (DME) eyes (n = 327) underwent anti-vascular endothelial growth factor (VEGF) treatments every 4 weeks for 52 weeks from a randomized controlled trial (CRTH258B2305, KINGFISHER) were included. OCT B-scan images through the foveal center at weeks 0, 4, 12, and 52, fundus photography, and retinal thickness (RT) maps were collected. GAN models were trained to generate probable OCT images after treatment. Input for each model were comprised of either the baseline B-scan alone or combined with additional OCT, thickness map, or fundus images. Generated OCT B-scan images were compared with real week 52 images.<BR><B>UNASSIGNED: </B>For 30 test images, 28, 29, 15, and 30 gradable OCT images were generated by CycleGAN, UNIT, Pix2PixHD, and RegGAN, respectively. In comparison with the real week 52, these GAN models showed positive predictive value (PPV), sensitivity, specificity, and kappa for residual fluid ranging from 0.500 to 0.889, 0.455 to 1.000, 0.357 to 0.857, and 0.537 to 0.929, respectively. For hard exudate (HE), they were ranging from 0.500 to 1.000, 0.545 to 0.900, 0.600 to 1.000, and 0.642 to 0.894, respectively. Models trained with week 4 and 12 B-scans as additional inputs to the baseline B-scan showed improved performance.<BR><B>UNASSIGNED: </B>GAN models could predict residual fluid and HE after long-term anti-VEGF treatment of DME.<BR><B>UNASSIGNED: </B>The implementation of this tool may help identify potential nonresponders after long-term treatment, thereby facilitating management planning for these eyes.